ASH will host its annual State-of-the-Art Symposium (SAS) meeting in Chicago, Il, September 23-24. This meeting will present the most current developments in key areas of hematology and give attendees the opportunity to explore the impact of new data on current practice. The topics that will be featured during this year’s SAS meeting include: monoclonal gammopathy consults, amyloidosis, relapsed myeloma, hematopoietic growth factors, monoclonal B-cell lymphocytosis, and large granular lymphocyte disorders. New this year, ASH is offering a session titled “The Great Debate: Instituting Myeloma Therapy – Synergy vs. Sequence,” which will feature two speakers weighing in on myeloma treatment strategies. A session on new oral thrombin inhibitors – when and when not to use – will also be offered. Registration is now open. For more information and to register for this meeting, go to www.hematology.org/Meetings/State-of-the-Art-Symposium.
back to top